Heart Failure

T. L. De Backer, A. A. Mangoni

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Older patients are the fastest growing and the most heterogeneous population. As many diseases occur more frequently with advancing age, so do cardiovascular diseases as well, and “cardiogeriatrics” has become an established term/specialty. Heart failure (HF) specifically is a highly prevalent disease in the older population. Most established standard treatments are effective in this group. However, the presence of comorbidities, polypharmacy, and frailty makes the management of HF in older patients more complex, and the benefit-risk of each treatment must be carefully weighed by a multidisciplinary team and shared with the patient and/or his/her relatives as part of a shared decision-making and a personalised care plan. We should keep in mind that we treat people, not diseases.

Original languageEnglish
Title of host publicationOptimizing Pharmacotherapy in Older Patients
Subtitle of host publicationAn Interdisciplinary Approach
EditorsAntonio Cherubini, Arduino A. Mangoni, Denis O’Mahony, Mirko Petrovic
Place of PublicationCham, Switzerland
PublisherSpringer Nature
Chapter19
Pages239-267
Number of pages29
ISBN (Electronic)978-3-031-28061-0
ISBN (Print)978-3-031-28060-3
DOIs
Publication statusPublished - 2023

Publication series

NamePractical Issues in Geriatrics
VolumePart F12
ISSN (Print)2509-6060
ISSN (Electronic)2509-6079

Keywords

  • Adverse drug events
  • Benefit-risk
  • Cardiogeriatrics
  • Cardiovascular diseases (CVD)
  • Comorbidities
  • Comprehensive geriatric assessment
  • Frailty
  • Heart failure (HF)
  • Heart failure with mildly reduced or midrange ejection fraction (HFmrEF)
  • Heart failure with preserved ejection fraction (HFpEF)
  • Heart failure with reduced ejection fraction (HFrEF)
  • Multidisciplinary
  • New York Heart Association (NYHA) class
  • Older persons
  • Personalised care
  • Polypharmacy
  • Underprescription

Fingerprint

Dive into the research topics of 'Heart Failure'. Together they form a unique fingerprint.

Cite this